The Federation of Indian Pilots (FIP) has formally urged the Directorate General of Civil Aviation (DGCA) to modernize its approach to pilot drug screening. In a representation dated August 17, 2026, FIP President Capt. CS Randhawa recommended the introduction of oral-fluid, or saliva, drug testing for pilots.
Context: Air India Incident Spurs Action
This call for updated testing protocols comes shortly after an incident involving Air India flight AI2379, flying from Phuket to Delhi on August 4. The aircraft experienced a hydraulic failure, leading to a sudden loss of approximately 300 feet of altitude and injuring 17 people onboard. Media reports later indicated that the pilot-in-command tested positive for marijuana in a confirmatory test, prompting Air India to mandate psychoactive-substance testing for its pilots, with several more reportedly showing non-negative preliminary results.
Benefits of Oral-Fluid Testing
FIP's proposal advocates for oral-fluid testing to complement, not immediately replace, the existing urine-based system, which has been in effect since January 31, 2022. The federation highlighted several advantages of saliva testing:
- Faster Collection: Oral fluid collection is generally simpler and quicker than urine tests.
- Direct Observability: Collection can be directly observed, reducing the potential for tampering.
- On-Site Capability: Tests can often be undertaken at or near the workplace or airport, streamlining the process.
An FIP study suggested that switching to oral-fluid collection could theoretically reduce collection workload significantly, though they stressed these are illustrative assumptions requiring validation under Indian conditions.
International Precedent and Broader Recommendations
FIP pointed to international examples where oral-fluid testing is already authorized for aviation personnel. Australia's Civil Aviation Safety Authority and the US Department of Transportation both expressly provide for oral-fluid testing, while the UAE's GCAA allows on-site oral-fluid screening. Beyond testing methods, FIP also proposed:
- Increased Random Testing: Raising annual random-testing coverage from 10% to at least 25% of pilots, allowing for multiple selections per year.
- Confidential Medication Disclosure: A system for pilots to confidentially disclose legitimate medications that might affect test results or performance.
- Awareness Program: A mandatory "Check Before You Take" program to educate pilots about common medicines, supplements, and prescriptions that could impact alertness or drug test findings.
The federation emphasized that detecting a substance does not automatically imply impairment. They stressed that the existing multi-step process—Screening, Confirmatory Laboratory Testing, Medical Review, and Final Regulatory Determination—should remain in place regardless of the initial testing method.
Proposed Pilot Program
To ensure a smooth transition and validate the effectiveness under local conditions, FIP has proposed a 12-month controlled pilot program at selected airlines and airports. This trial would compare oral-fluid and urine testing methods before any permanent changes are made to civil aviation regulations. FIP has offered to share its detailed study with the DGCA and requested a technical consultation involving all relevant stakeholders and subject-matter experts.